Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Eye, Ocular, Optometry, Ophthalmology, Vision Health Companies

MacuCLEAR Inc

Parents

*WBT:Candidate Companies (2009)
Amt: 1M Round: Series A Investor(s) Central Texas Angel Network (2012)
Central Texas Angel Network investments tripled in 2009-MacuClear Inc., a developer of an age-related-macular degeneration treatment, received $900,000
Currently no approved treatment for 90% who have this disease.
It is at the Phase II human clinical trials stage
It’s first target is Age Related Macular Degeneration, (AMD), the leading cause of blindness for people over 50 years of age, af
MacuCLEAR obtained, through an exclusive worldwide license from Texas A&M University, MacuCLEAR Inc
Specialty clinical-stage pharmaceutical company focused on developing and commercializing novel solutions for vascular disorders
The company currently has 4 patents around this technology.